Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000-2021

Abstract

Background: This study assessed the epidemiology of hepatitis delta virus (HDV) within the University of Utah UHealth health care system (2000-2021). Methods: Analysis of HDV/HBV testing, diagnostic codes, liver enzymes, and comorbidities was performed. Results: Among the 1962 HBV patients, only 22.2% underwent HDV testing, revealing an 8.3% positivity rate for HDV coinfections. This study observed a consistent increase in HBV and HDV cases, with higher HDV detection rates linked to increased testing. Limited HDV testing and potential screening biases were evident. Discussion: Improved HDV testing and surveillance are crucial for early detection and implementation of targeted therapies.